Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe | 1yr
Life Sciences - Page 5
Tie-up to create firm with revenues of $810m and more than 1,000 lawyers | 1yr
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 1yr
Troutman Pepper Locke to have 1,600 lawyers across 33 US and two European offices | 1yr
The second edition of the Family Asset Protection Law Guide is written by leading family law and contentious trusts specialists from around the world. | 10mos
Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 1yr
The way the request was processed still raises ‘significant concerns’, says the firm | 1yr
Nickolas Bogdanovich joins after Cleary M&A partner James Langston defected to Paul Weiss in May | 1yr
Firm hires from Goodwin for fifth California office | 2yrs
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 2yrs
PEP rises 7% to £1,076k after flatlining in FY23 | 2yrs
Pan-European patent court delivers first revocation judgment a year and a month after opening | 2yrs
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 2yrs
Raleigh office will target healthcare work and is top 50 firm’s 23rd US base | 2yrs
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 2yrs
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 2yrs
IP and disputes group’s move follows ArentFox Schiff adding automotive partner quartet from Burns in Boston in April | 2yrs
Team moves over from Lerner David strengthening medical device practice | 2yrs
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 2yrs
Tobias Knapp joins as co-head of global firm’s New York transactional group | 2yrs
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences | 2yrs